ROBERT S MITCHELL
Vehicle Board in Gardenville, PA
License number
Pennsylvania MV241502
Category
Vehicle Board
Type
Vehicle Salesperson
Address
Address
Gardenville, PA 18901
Personal information
See more information about ROBERT S MITCHELL at radaris.comName
Address
Phone
506 S 49Th St, Philadelphia, PA 19143
5036 Westbury Farms Dr, Erie, PA 16506
509 Tatnall Ave, Glenolden, PA 19036
4 Herr Ct, Newport, PA 17074
500 Connellsville St, Uniontown, PA 15401
Professional information
See more information about ROBERT S MITCHELL at trustoria.com
Use Of Estrogen Receptor Alpha Modulators For The Treatment Of Multiple Sclerosis
Use Of Estrogen Receptor Alpha Modulators For The Treatment Of Multiple Sclerosis
US Patent:
2004016, Aug 26, 2004
Filed:
Jan 5, 2004
Appl. No.:
10/751543
Inventors:
M. Elloso - Devon PA, US
Robert Mitchell - Doylestown PA, US
Douglas Harnish - Pennsburg PA, US
Steven Adelman - Doylestown PA, US
Robert Mitchell - Doylestown PA, US
Douglas Harnish - Pennsburg PA, US
Steven Adelman - Doylestown PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K031/56, A61K031/137
US Classification:
514/182000, 514/649000
Abstract:
The present invention provides methods of treating an autoimmune pathology in a mammal, comprising administering an agent with estrogen receptor agonist activity in particular a selective estrogen receptor modulator, to the mammal in an amount sufficient to decrease production of TH-1 and/or TH-2 cytokines. Also provided is a method of selecting compounds useful for the treatment of multiple sclerosis, comprising selecting a compound which has estrogen receptor agonist activity.
Method Of Treating Hyperproliferative Vascular Disease
Method Of Treating Hyperproliferative Vascular Disease
US Patent:
5288711, Feb 22, 1994
Filed:
Apr 28, 1992
Appl. No.:
7/874895
Inventors:
Robert D. Mitchell - Doylestown PA
Stephen Skwish - Mercer NJ
Stephen Skwish - Mercer NJ
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 3171, A61K 31725
US Classification:
514 56
Abstract:
This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of a combination of rapamycin and heparin.
Medrogestrone Production
Medrogestrone Production
US Patent:
5428151, Jun 27, 1995
Filed:
May 5, 1994
Appl. No.:
8/239187
Inventors:
Michael W. Winkley - St. Albans VT
Robert D. Mitchell - Doylestown PA
Robert D. Mitchell - Doylestown PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
C07J 700, C07J 7100
US Classification:
540 60
Abstract:
A process for the production of medrogestone, in which, in an intermediate step, the solvate 3. beta. ,5. alpha. ,6. beta. -trihydroxy-6. alpha. ,17. alpha. -dimethylpregnan-20- one monomethanolate is obtained as a solid, stable compound by displacing the organic solvent from a solution of of 3. beta. ,5. alpha. ,6. beta. -trihydroxy-6. alpha. ,17. alpha. -dimethylpregnan-20- one with a lower alkanol, and a Diels-Alder adduct of 6-methylene-17. alpha. -methylpregn-4-ene-3,20-dione with maleic anhydride is used as an intermediate for production of the corresponding dicarboxylic acid salt for removal of 6-methylene-17. alpha. -methylpregn-4-ene-3,20-dione contamination of the desired product. Another intermediate, 6. beta. -hydroxy-6. alpha. ,17. alpha.